Pegylated Recombinant Human Erythropoietin
About Pegylated Recombinant Human Erythropoietin
Pegylated Recombinant Human Erythropoietin belongs to the group of medicines called Erythropoiesis-Stimulating Agents (ESAs), which are used to treat Anemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy. Anaemia refers to low blood counts due to a deficiency of the blood component hemoglobin, which results in a reduced oxygen-carrying capacity of the blood.
Pegylated Recombinant Human Erythropoietin contains Pegylated Recombinant Human Erythropoietin, which works by stimulating the bone marrow to produce more red blood cells, thereby correcting low blood counts and anaemia.
Sometimes, Pegylated Recombinant Human Erythropoietin may cause specific common side effects such as nausea, vomiting, diarrhoea and fever. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects consistently.
Please inform the doctor of your detailed medical history, including hypertension, heart disease, heart attack, stroke, epilepsy, cancer, liver disease, thromboembolism, porphyria and/or pure red cell aplasia (where the bone marrow cannot produce enough RBCs). Before receiving this medicine, inform the doctor if you are pregnant, breastfeeding or taking any other medication.
Uses of Pegylated Recombinant Human Erythropoietin
• Treats anaemia in chronic kidney disease: Pegylated Recombinant Human Erythropoietin helps stimulate red blood cell production in patients with reduced kidney function.
• Manages anaemia due to cancer chemotherapy: Pegylated Recombinant Human Erythropoietin supports the treatment of anaemia in patients undergoing chemotherapy for cancer.
• Addresses anaemia related to HIV therapy: Pegylated Recombinant Human Erythropoietin is used to correct anaemia that develops as a side effect of HIV treatments.
Medicinal Benefits
Pegylated Recombinant Human Erythropoietin is an Erythropoiesis-Stimulating agent (ESA). It contains Recombinant Human Erythropoietin Alfa used to treat anaemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy. It stimulates the bone marrow to produce more red blood cells, thereby correcting any low blood counts and anaemia.
Directions for Use
Storage
Side Effects of Pegylated Recombinant Human Erythropoietin
- Nausea
- Diarrhoea
- Vomiting
- Fever
Drug Warnings
Inform the doctor if you have an allergy to any of its components. Please inform the doctor of your detailed medical history, including hypertension, heart disease, myocardial infarction, stroke, epilepsy, head and neck cancers, liver disease, thromboembolism, porphyria and/or pure red cell aplasia (where the bone marrow cannot produce enough RBCs). Inform your doctor of any medicines you may be taking, especially if you are on any immunosuppressants, blood thinners or blood stimulants. Please inform your doctor before receiving Pegylated Recombinant Human Erythropoietin during pregnancy and nursing.
Drug Interactions
Drug-Drug Interaction: No interactions found.
Drug-Food Interaction: No interactions found.
Drug-Disease Interaction: Inform your doctor if you have heart, liver or kidney disease before receiving Pegylated Recombinant Human Erythropoietin.
Drug-Drug Interactions Checker List:
Safety Advice
Alcohol
consult your doctorThere is not enough literature to explain the effects of alcohol. Consult your doctor if you have any concerns.
Pregnancy
cautionIf you are pregnant or planning to become pregnant, inform your doctor. Your doctor will weigh the benefits against the risks.
Breast Feeding
cautionLet your doctor know if you are a nursing mother before taking Pegylated Recombinant Human Erythropoietin; your doctor will decide whether breastfeeding mothers can use Pegylated Recombinant Human Erythropoietin or not.
Driving
cautionIt's unclear whether Pegylated Recombinant Human Erythropoietin affects driving abilities, so don't drive or operate machinery if you're having trouble concentrating or reacting.
Liver
cautionPegylated Recombinant Human Erythropoietin should be used with caution in patients suffering from liver diseases. Please inform your doctor before receiving it.
Kidney
cautionPegylated Recombinant Human Erythropoietin should be used with caution in patients suffering from kidney diseases. Please inform your doctor before receiving it.
Children
safe if prescribedPegylated Recombinant Human Erythropoietin can be used for children who are prescribed pediatric doses.
Habit Forming
Diet & Lifestyle Advise
- As nausea and vomiting may occur using Pegylated Recombinant Human Erythropoietin, make sure to take it on light, small meals.
- To promote blood production, eat red fruits and vegetables, such as apples, pomegranates, dry fruits, beans, and nuts.
- Avoid caffeine and alcohol as these can precipitate bleeding.
- Take care of your mental health. Stress is a huge factor that can cause excessive bleeding. Make sure you meditate daily in the morning.
- Yoga has also proven very effective in preventing excessive blood loss. The butterfly pose is one of the best poses for treating heavy periods.
- Make sure you drink a lot of water and keep yourself hydrated. Fluid intake helps flush out toxins.
Special Advise
- Do not self-inject before proper training.
- Exercise caution in case of a history of allergic disorders, a known latex allergy, or any of the components of Pegylated Recombinant Human Erythropoietin.
- Please inform the doctor immediately if you notice any anaphylaxis (allergy, skin changes, difficulty in breathing, anxiety, confusion, dizziness, etc) post-injection.
- Your doctor may advise blood tests regularly to check your need and tolerance of Pegylated Recombinant Human Erythropoietin.
Patients Concern
Disease/Condition Glossary
Anaemia: Anaemia is a condition in which the production of red blood cells is reduced or compromised, hampering the blood's oxygen-carrying capacity. This results in reduced oxygen reaching the vital tissues of organs, leading to symptoms like lethargy, weakness, shortness of breath, paleness, mood changes, neuropathy, etc.
FAQs
Pegylated Recombinant Human Erythropoietin belongs to the group of medicines called Erythropoiesis-Stimulating Agents (ESAs), which are used to treat Anemia caused by chronic kidney disease, cancer chemotherapy, or HIV therapy.
Pegylated Recombinant Human Erythropoietin contains Pegylated Recombinant Human Erythropoietin, which works by stimulating the bone marrow to produce more red blood cells, thereby correcting low blood counts and anaemia.
Consult your doctor before taking iron supplements along with Pegylated Recombinant Human Erythropoietin as they might increase the effectiveness of Pegylated Recombinant Human Erythropoietin when taken together.
Pegylated Recombinant Human Erythropoietin is considered safe at the doses administered by the physician. However, consult your doctor if you experience any unusual side effects.
The common side effects of Pegylated Recombinant Human Erythropoietin may include nausea, vomiting, diarrhoea, and fever. Most of these side effects do not require medical attention and will resolve gradually over time. However, you are advised to talk to your doctor if you experience these side effects consistently.
You can store Pegylated Recombinant Human Erythropoietin in the refrigerator or a cool, dry place away from sunlight. Do not freeze. Use at room temperature only.
